Yixintang Pharmaceutical (002727.SZ) announced on November 26 that the company held the 12th meeting of the sixth board of directors and the 12th meeting of the sixth board of supervisors on November 26, 2024. It deliberated and passed the proposal on changing the use of part of the raised funds and using the raised funds to increase capital to its subsidiary to implement investment projects. It plans to use 109 million yuan of the raised funds from the company's investment project 'traditional chinese medicine tablet production capacity expansion project' to implement the new project 'Yixintang (Sichuan) Health Wisdom Pharmaceutical Base Phase One Logistics Center Project (Phase One)', and increase capital to Yixintang Pharmaceutical (Sichuan) Co., Ltd. to implement the investment project. This change in the use of part of the raised funds and the increase in capital to the subsidiary to implement the investment project is subject to the approval of the third interim shareholders' meeting in 2024.